Notes
Funded by Boehringer Ingelheim.
Randomized Evaluation of Long-Term Anticoagulation Therapy.
Reference
Clemens A, et al. Efficacy and Cost-Effectiveness of Dabigatran Etexilate Versus Warfarin in Atrial Fibrillation in Different Age Subgroups. American Journal of Cardiology : 2 Jul 2014. Available from: URL: http://doi.org/10.1016/j.amjcard.2014.06.015
Rights and permissions
About this article
Cite this article
Dabigatran cost effective in AF patients regardless of age. PharmacoEcon Outcomes News 710, 10 (2014). https://doi.org/10.1007/s40274-014-1483-x
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40274-014-1483-x